Symmetry Investments’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$557K Buy
231,000
+31,000
+16% +$74.7K 0.04% 88
2025
Q1
$442K Buy
200,000
+135,000
+208% +$298K 0.03% 84
2024
Q4
$354K Buy
65,000
+30,000
+86% +$164K 0.02% 122
2024
Q3
$291K Sell
35,000
-80,000
-70% -$665K 0.04% 89
2024
Q2
$823K Buy
+115,000
New +$823K 0.09% 106